BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hou L, Rong J, Haider A, Ogasawara D, Varlow C, Schafroth MA, Mu L, Gan J, Xu H, Fowler CJ, Zhang MR, Vasdev N, Ametamey S, Cravatt BF, Wang L, Liang SH. Positron Emission Tomography Imaging of the Endocannabinoid System: Opportunities and Challenges in Radiotracer Development. J Med Chem 2021;64:123-49. [PMID: 33379862 DOI: 10.1021/acs.jmedchem.0c01459] [Cited by in Crossref: 4] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 He Y, Grether U, Taddio MF, Meier C, Keller C, Edelmann MR, Honer M, Huber S, Wittwer MB, Heer D, Richter H, Collin L, Hug MN, Hilbert M, Postmus AGJ, Stevens AF, van der Stelt M, Krämer SD, Schibli R, Mu L, Gobbi LC. Multi-parameter optimization: Development of a morpholin-3-one derivative with an improved kinetic profile for imaging monoacylglycerol lipase in the brain. Eur J Med Chem 2022;243:114750. [PMID: 36137365 DOI: 10.1016/j.ejmech.2022.114750] [Reference Citation Analysis]
2 Fu H, Rong J, Chen Z, Zhou J, Collier T, Liang SH. Positron Emission Tomography (PET) Imaging Tracers for Serotonin Receptors. J Med Chem 2022. [PMID: 35939391 DOI: 10.1021/acs.jmedchem.2c00633] [Reference Citation Analysis]
3 Gündel D, Deuther-Conrad W, Ueberham L, Kaur S, Otikova E, Teodoro R, Toussaint M, Lai TH, Clauß O, Scheunemann M, Bormans G, Bachmann M, Kopka K, Brust P, Moldovan RP. Structure-Based Design, Optimization, and Development of [18F]LU13: A Novel Radioligand for Cannabinoid Receptor Type 2 Imaging in the Brain with PET. J Med Chem 2022. [PMID: 35771668 DOI: 10.1021/acs.jmedchem.2c00256] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Nowak-Jary J, Machnicka B. Pharmacokinetics of magnetic iron oxide nanoparticles for medical applications. J Nanobiotechnology 2022;20:305. [PMID: 35761279 DOI: 10.1186/s12951-022-01510-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Cheng R, Fujinaga M, Yang J, Rong J, Haider A, Ogasawara D, Van RS, Shao T, Chen Z, Zhang X, Calderon Leon ER, Zhang Y, Mori W, Kumata K, Yamasaki T, Xie L, Sun S, Wang L, Ran C, Shao Y, Cravatt B, Josephson L, Zhang MR, Liang SH. A novel monoacylglycerol lipase-targeted 18F-labeled probe for positron emission tomography imaging of brown adipose tissue in the energy network. Acta Pharmacol Sin 2022. [PMID: 35513432 DOI: 10.1038/s41401-022-00912-8] [Reference Citation Analysis]
6 Navarro D, Gasparyan A, Navarrete F, Torregrosa AB, Rubio G, Marín-Mayor M, Acosta GB, Garcia-Gutiérrez MS, Manzanares J. Molecular Alterations of the Endocannabinoid System in Psychiatric Disorders. Int J Mol Sci 2022;23:4764. [PMID: 35563156 DOI: 10.3390/ijms23094764] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Lam F, Chu J, Choi JS, Cao C, Hitchens TK, Silverman SK, Liang ZP, Dilger RN, Robinson GE, Li KC. Epigenetic MRI: Noninvasive imaging of DNA methylation in the brain. Proc Natl Acad Sci U S A 2022;119:e2119891119. [PMID: 35235458 DOI: 10.1073/pnas.2119891119] [Reference Citation Analysis]
8 Arakawa R, Takano A, Nag S, Jia Z, Amini N, Maresca KP, Zhang L, Keliher EJ, Butler CR, Piro JR, Samad TA, Smith D, Nason D, O'Neil S, Trapa P, Fonseca KR, Litchfield J, McCarthy T, Carson RE, Halldin C. Target occupancy study and whole-body dosimetry with a MAGL PET ligand [11C]PF-06809247 in non-human primates. EJNMMI Res 2022;12:13. [PMID: 35244788 DOI: 10.1186/s13550-022-00882-2] [Reference Citation Analysis]
9 He Y, Gobbi LC, Herde AM, Rombach D, Ritter M, Kuhn B, Wittwer MB, Heer D, Hornsperger B, Bell C, O'hara F, Benz J, Honer M, Keller C, Collin L, Richter H, Schibli R, Grether U, Mu L. Discovery, synthesis and evaluation of novel reversible monoacylglycerol lipase radioligands bearing a morpholine-3-one scaffold. Nuclear Medicine and Biology 2022. [DOI: 10.1016/j.nucmedbio.2022.02.002] [Reference Citation Analysis]
10 He Y, Schild M, Grether U, Benz J, Leibrock L, Heer D, Topp A, Collin L, Kuhn B, Wittwer M, Keller C, Gobbi LC, Schibli R, Mu L. Development of High Brain-Penetrant and Reversible Monoacylglycerol Lipase PET Tracers for Neuroimaging. J Med Chem 2022. [PMID: 35089028 DOI: 10.1021/acs.jmedchem.1c01706] [Reference Citation Analysis]
11 Chen Z, Haider A, Chen J, Xiao Z, Gobbi L, Honer M, Grether U, Arnold SE, Josephson L, Liang SH. The Repertoire of Small-Molecule PET Probes for Neuroinflammation Imaging: Challenges and Opportunities beyond TSPO. J Med Chem 2021;64:17656-89. [PMID: 34905377 DOI: 10.1021/acs.jmedchem.1c01571] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
12 De Pol M, Kolla NJ. Endocannabinoid markers in autism spectrum disorder: A scoping review of human studies. Psychiatry Res 2021;306:114256. [PMID: 34775294 DOI: 10.1016/j.psychres.2021.114256] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Ma L, Wu S, Zhang K, Tian M, Zhang H. Progress on the application of positron emission tomography imaging of cannabinoid type 1 receptor in neuropsychiatric diseases. Zhejiang Da Xue Xue Bao Yi Xue Ban 2021;50:666-73. [PMID: 34986538 DOI: 10.3724/zdxbyxb-2021-0063] [Reference Citation Analysis]
14 Yamasaki T, Hatori A, Zhang Y, Mori W, Kurihara Y, Ogawa M, Wakizaka H, Rong J, Wang L, Liang S, Zhang MR. Neuroprotective effects of minocycline and KML29, a potent inhibitor of monoacylglycerol lipase, in an experimental stroke model: a small-animal positron emission tomography study. Theranostics 2021;11:9492-502. [PMID: 34646382 DOI: 10.7150/thno.64320] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Rong J, Mori W, Xia X, Schafroth MA, Zhao C, Van RS, Yamasaki T, Chen J, Xiao Z, Haider A, Ogasawara D, Hiraishi A, Shao T, Zhang Y, Chen Z, Pang F, Hu K, Xie L, Fujinaga M, Kumata K, Gou Y, Fang Y, Gu S, Wei H, Bao L, Xu H, Collier TL, Shao Y, Carson RE, Cravatt BF, Wang L, Zhang MR, Liang SH. Novel Reversible-Binding PET Ligands for Imaging Monoacylglycerol Lipase Based on the Piperazinyl Azetidine Scaffold. J Med Chem 2021;64:14283-98. [PMID: 34569803 DOI: 10.1021/acs.jmedchem.1c00747] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
16 Ni R, Müller Herde A, Haider A, Keller C, Louloudis G, Vaas M, Schibli R, Ametamey SM, Klohs J, Mu L. In vivo Imaging of Cannabinoid Type 2 Receptors: Functional and Structural Alterations in Mouse Model of Cerebral Ischemia by PET and MRI. Mol Imaging Biol 2021. [PMID: 34642898 DOI: 10.1007/s11307-021-01655-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
17 Teodoro R, Gündel D, Deuther-Conrad W, Ueberham L, Toussaint M, Bormans G, Brust P, Moldovan RP. Development of [18F]LU14 for PET Imaging of Cannabinoid Receptor Type 2 in the Brain. Int J Mol Sci 2021;22:8051. [PMID: 34360817 DOI: 10.3390/ijms22158051] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
18 Kwan Cheung KA, Mitchell MD, Heussler HS. Cannabidiol and Neurodevelopmental Disorders in Children. Front Psychiatry 2021;12:643442. [PMID: 34093265 DOI: 10.3389/fpsyt.2021.643442] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]